GlobalData Healthcare
-
16 Jul
The boom in medical cannabis research is set to continue
Cannabis has been receiving some serious media attention in 2018, and a rise in medical cannabis research is following.
-
13 Jul
Harmful algal blooms: the US is facing a growing epidemic
Harmful algal blooms (HABs) have been reported in every US coastal state and their occurrence is likely on the rise, according to the US National Oceanic and Atmospheric Administration (NOAA).
-
28 Jun
Merck turns to blockchain to tackle counterfeit drugs
Pharma giant Merck is seeking a patent for a blockchain-based system to track objects as they navigate through the supply chain.
-
15 Jun
Tick-borne diseases on the rise: what can be done?
Cases of tick-borne diseases are on the rise globally, with Lyme disease patients increasing by over three-fold in the US alone in the past couple years.
-
5 Jun
US-China trade war could wipe out US-based generics manufacturing
US President Trump’s proposed tariffs on China could ignite a US-China trade war and destabilise an already shaky pharma industry.
-
30 May
Can machine learning predict the onset of autism?
The early and accurate diagnosis of autism spectrum disorder (ASD) in children is crucial.
-
27 Apr
A combined Takeda Shire would be the ninth biggest pharma company in the world by sales
Takeda’s possible $65 billion takeover of Shire could be the largest deal value in pharma this year and combined Takeda Shire company could be catapulted to the ninth position in terms of 2017 sales.
-
24 Apr
World Malaria Day: Global malaria eradication could be realistic within the next 15 years
The theme of World Malaria Day 2018 is “Ready to Beat Malaria”, highlighting the collective global goal to end the disease.
-
18 Apr
Marijuana is a possible solution to the opioid crisis
In 2016, more than 110 people died every day due to opioid overdose in the US.
-
13 Mar
Early cancer diagnoses can be both a blessing and a curse
Many research groups and private companies are attempting to develop a test that can accurately and effectively determine whether or not a person has cancer.
-
12 Feb
US tax reform could initiate the next wave of pharma M&A
The US Senate passed the country’s first major tax reform in over 30 years last month, and the ramifications on the pharmaceutical industry could be vast.
-
12 Feb
Smart watches are using artificial intelligence to detect diabetes
Wearable devices can be used to detect the early signs of diabetes using an artificial intelligence (AI) network called DeepHeart and developed by Cardiogram, a study has found.
-
7 Feb
NHS staff: Trump’s attack on the “broke” NHS has hit too close to home
Earlier this week US president Donald Trump described the UK’s National Health Service (NHS) as “going broke and not working.” Although many were quick to criticise him this description may hit too close to home for some in the NHS.
-
29 Jan
Robot surgery is growing faster than humans can handle
With increasingly intelligent artificial intelligence (AI), even high level surgeons might soon be finding themselves replaced by robots as AI exceeds human abilities.
-
29 Jan
It is time for the UK to adopt the US flu vaccine
Flu season now is in full swing, with four strains in circulation this year.
-
19 Jan
Non-profit hospitals in the US are teaming up to create cheap, generic drugs
Long suffering patients in US hospital have for years had to pay for expensive drugs because cheaper alternatives are in short supply.
-
16 Jan
Merck is the pharmaceutical company to watch in 2018
In the pharmaceutical industry one well performing drug can make or break a company’s year.
-
25 Oct
Social media can be used as a weapon in the war against anti-vaxxers
People that think vaccines are dangerous — so-called anti-vaxxers — are a small but dangerous group.
-
16 Oct
Women make up 70 percent of Alzheimer’s cases around the world and we don’t know why
In all developed countries around the world women are more likely than men to be diagnosed with Alzheimer’s.
-
13 Oct
We’re not going to win the fight against melanoma any time soon
Despite a rise in awareness of the dangers of sun damage to the skin the number of people diagnosed with melanoma is expected to rise in both men and women between now and 2026.
-
6 Oct
AI is coming to healthcare: here’s how it’s going to change the industry
Artificial intelligence (AI) is coming to almost every aspect of day-to-day life.
-
12 Sep
Women are far more likely to get migraines than men
Migraines are relatively common, affecting approximately 11 percent of the world’s adult population.
-
4 Sep
More speciality drugs are coming onto the market than ever before. Why?
The number of drugs picking up a designation from regulators — first treatments or speciality drugs — across the European Union, the US, and Japan have risen by 117 percent in 10 years.
-
7 Aug
These companies have done the most clinical trials in Japan since 2012
Novartis, the Swiss multinational pharma giant, carried out the most clinical trials in Japan since 2012, with almost 150.
-
18 Jul
The NHS hopes that data and the model hospital will save it money – but what does it mean for medtech companies?
Healthcare systems around the world are under unprecedented financial pressure.
-
4 Jul
Humira — the highest gross-selling drug in the world — isn’t done yet
Humira has set a record for the highest gross-selling drug in the world and contributed 63 percent to AbbVie’s revenue in 2016 alone and expectations are high the blockbuster drug will continue to perform.
-
3 Jul
Gene editing: democratic evolution or encoding privilege?
The ability to edit the human genome has been eagerly anticipated for many years.
-
20 Jun
Medtech: what the uncertain UK general election means for the industry
While uncertainty has been a theme for most sectors in the UK over recent months, the medical technology (medtech) industry has suffered more than most.
-
26 May
Antibiotic resistance: Could we be looking at the death of medicine?
Heart surgery, prenatal care, organ transplants, and blood transfusions.
-
24 May
China public hospital reform: a storm is coming
There is bad news for global pharmaceutical and medical devices companies; China has developed a set-in-stone timetable to conduct government-driven price management and reimbursement controls.